Abstract
For both hepatoblastomas and hepatocellular carcinoma, knowledge regarding distinct pathologic phenotypes has undergone considerable expansion, what has resulted in novel and more refined classifications of these tumors. These morphotypes are increasingly supplemented by cytogenetic and molecular findings, leading to characteristic signatures. It is expected that these findings will be the baseline for improved risk stratifications to be employed for novel treatment strategies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abbondanzo SL, Manz HJ, Klappenbach RS et al (1986) Hepatocellular carcinoma in an 11-year-old girl with Fanconi’s anemia. Report of a case and review of the literature. Am J Pediatr Hematol Oncol 8:334–337
Abenoza P, Manivel JC, Wick MR et al (1987) Hepatoblastoma: an immunohistochemical and ultrastructural study. Hum Pathol 18:1025–1035
Akmal SN, Yun K, MacLay J et al (1995) Insulin-like growth factor 2 and insulin-like factor binding protein 2 expression in hepatoblastoma. Hum Pathol 26:846–851
Anders RA, Yerian LM, Tretiakova M et al (2003) cDNA microarray analysis of macroregenerative and dysplastic nodules in end-stage hepatitis C virus-induced cirrhosis. Am J Pathol 162:991–1000
Ara T, Fukuzawa M, Oue T et al (1997) Immunohistochemical assessment of the MIB-1 labeling index in human hepatoblastoma and its prognostic relevance. J Pediatr Surg 32:1690–1694
Aravalli RN, Steer CJ, Cressman EN et al (2008) Molecular mechanisms of hepatocellular carcinoma. Hepatology 48:2047–2063
Bannasch P (1996) Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular, and metabolic changes. Prog Liver Dis 14:161–197
Behrle FC, Mantz FA, Olson RL et al (1963) Virilization accompanying hepatoblastoma. Pediatrics 32:265–271
Bellani FF, Massimino M (1993) Liver tumors in childhood: epidemiology and clinics. J Surg Oncol Suppl 3:119–121
Berman MA, Burnham JA, Sheahan DG et al (1988) Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature. Hum Pathol 19:784–794
Bianchi L (1993) Glycogen storage disease I and hepatocellular tumours. Eur J Pediatr 152(Suppl 1):S63–S70
Blanc JF, Lalanne C, Plomion C et al (2005) Proteomic analysis of differently expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. Proteomics 5:3778–3789
Borman JB, Harbott AJ, Morris D (1961) Hepatic lobectomy in infancy for hepatoblastoma. Br J Surg 49:11–13
Braunstein GD, Bridson WE, Glass A et al (1972) In vivo and in vitro production of human chorionic gonadotropin and alpha-fetoprotein by a virilizing hepatoblastoma. J Clin Endocrinol 35:857–862
Bréchot C (2004) Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 127(Suppl 1):S56–S61
Brodsky SV, Sandoval C, Sharma N et al (2008) Recurrent nested stromal epithelial tumor of the liver with extrahepatic metastasis: case report and review of literature. Pediatr Dev Pathol 11:469–473
Brotto M, Finegold MJ (2002) Distinct patterns of p27/KIP1 gene expression in hepatoblastoma and prognostic implications with correlation before and after chemotherapy. Hum Pathol 33:198–205
Buendia MA (2000) Genetics of hepatocellular carcinoma. Semin Cancer Biol 10:185–200
Buendia MA (2002) Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects. Med Pediatr Oncol 39:530–535
Capurro M, Wanless IR, Sherman M et al (2003) Glypican-3: a novel serum and histochemical marker for hepatocelular carcinoma. Gastroenterology 125:89–97
Carriaga MT, Henson DE (1995) Liver, gallbladder, exrahepatic bile ducts, and pancreas. Cancer 75(Suppl):171–190
Chandra CR, Stocker JT (1992) The liver, gallbladder and biliary tract. In: Stocker JT (ed) Pediatric pathology. JB Lippincott, Philadelphia
Chang MH (2003) Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B immunization. Liver Int 23:309–314
Cieply B, Zeng G, Proverbs-Singh T et al (2009) Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene. Hepatology 49:821–831
Coire CI, Qizilbash AH, Castelli MF et al (1987) Hepatic adenomata in type Ia glycogen storage disease. Arch Pathol Lab Med 111:166–169
Conrad RJ, Gribbin D, Walker NI et al (1993) Combined cystic teratoma and hepatoblastoma of the liver. Probable divergent differentiation of an uncommitted hepatic precursor cell. Cancer 72:2910–2913
Conran RM, Hitchcock CL, Waclawiw MA et al (1992) Hepatoblastoma: the prognostic significance of histologic type. Pediatr Pathol 12:167–183
Cross SS, Variend S (1992) Combined hepatoblastoma and yolk sac tumor of the liver. Cancer 69:1323–1326
Czauderna P (2002) Adult type vs. childhood hepatocellular carcinoma – are they the same of different lesions? Med Pediatr Oncol 39:519–523
Dabbs DJ, Geisinger KR (2004) Recommendations for the reporting of tissues removed as part of the surgical treatment of malignant liver tumors. Hum Pathol 35:1315–1323
Dachman AH, Pakter RL, Ros PR et al (1987) Hepatoblastoma: radiologic-pathologic correlation in 50 cases. Radiology 164:15–19
D’Antiga L, Vallortigara F, Cillo U et al (2007) Features predicting unresectability in hepatoblastoma. Cancer 110:1050–1057
Darbari A, Sabin KM, Shapiro CN et al (2003) Epidemiology of primary hepatic malignancies in U.S. children. Hepatology 38:560–566
Davies JQ, de la Hall PM, Kaschula RO et al (2004) Hepatoblastoma – evolution of management and outcome and significance of histology of the resected tumor. A 31-year experience with 40 cases. J Pediatr Surg 39:1321–1327
Dehner LP (1978) Hepatic tumors in the pediatric age group: a distinctive clinicopathologic spectrum. Perspect Pediatr Pathol 4:217–268
Dehner LP, Manivel JC (1988) Hepatoblastoma: an analysis of the relationship between morphologic subtypes and prognosis. Am J Pediatr Hematol Oncol 10:301–307
De Ioris M, Brugieres L, Zimmermann A et al (2008) Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience. Eur J Cancer 44:545–550
Delpuech O, Trabut JB, Carnot F et al (2002) Identification, using cDNA macroarray analysis, of distinct gene expression profiles associated with pathological and virological features of hepatocellular carcinoma. Oncogene 21:2926–2937
Demers SI, Russo P, Lettre F et al (2003) Frequent mutation reversion inversely correlates with clinical severity in a genetic liver disease, hereditary tyrosinemia. Hum Pathol 34:1313–1320
Dicken BJ, Bigam DL, Lees GM (2004) Association between surgical margins and long-term outcome in advanced hepatoblastoma. J Pediatr Surg 39:721–725
Doss BJ, Vicari J, Jacques SM (1998) Placental involvement in congenital hepatoblastoma. Pediatr Dev Pathol 1:538–542
Douglass EC, Reynolds M, Finegold M et al (1993) Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study. J Clin Oncol 11:96–99
Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462–503
Edmondson HA (1956) Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood. AMA J Dis Child 91:168–186
El-Serag HB, Davila JA, Petersen NJ et al (2003) The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 139:817–823
Ettinger LJ, Freeman AI (1979) Hepatoma in a child with neurofibromatosis. Am J Dis Child 133:528–531
Farhi DC, Shikes RH, Murani PJ et al (1983) Hepatocellular carcinoma in young people. Cancer 52:1516–1525
Fasano M, Theise ND, Nalesnik M et al (1998) Immunohistochemical evaluation of hepatoblastomas with use of hepatocyte-specific marker, hepatocyte paraffin 1, and the polyclonal anti-carcinoembryonic antigen. Mod Pathol 11:934–938
Feusner JH, Krailo MD, Haas JE et al (1993) Treatment of pulmonary metastases of initial stage I hepatoblastoma in childhood. Report from the Childrens Cancer Group. Cancer 71:859–864
Finegold MJ, Lopez-Terrada DH, Bowen J et al (2007) Protocol for the examination of specimens from pediatric patients with hepatoblastoma. Arch Pathol Lab Med 131:520–529
Finegold MJ, Egler RA, Goss JA et al (2008) Liver tumors: pediatric population. Liver Trans 14:1545–1556
Forouhar FA, Quinn JJ, Cooke R et al (1984) The effect of chemotherapy on hepatoblastoma. Arch Pathol Lab Med 108:311–314
Fukuzawa R, Umezawa A, Ochi K et al (1999) High frequency of inactivation of the imprinted H19 gene in “sporadic” hepatoblastoma. Int J Cancer 82:490–497
Garcés-Inigo EF, Leung R, Sebire NJ et al (2009) Extrarenal rhabdoid tumours outside the central nervous system in infancy. Pediatr Radiol 39:817–822
Geoffroy-Perez B, Janin N, Ossian K et al (2001) Cancer risk in heterozygotes for ataxia-telangiectasia. Int J Cancer 93:288–293
Giardello FM, Petersen GM, Brensinger JD et al (1996) Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut 39:867–869
Gonzalez-Crussi F, Upton MP, Maurer HS (1982) Hepatoblastoma. Attempt at characterization of histologic subtypes. Am J Surg Pathol 6:599–612
Gonzalez-Crussi F (1991) Case 1 Undifferentiated small cell (“anaplastic”) hepatoblastoma. Pediatr Pathol 11:155–162
Gornicka B, Ziarkiewicz-Wroblewska B, Michalowicz B et al (2001) Immature hepatic tumor of bimodal differentiation in a young adult patient: a novel lesion expressing β-catenin and mimicking a distinct phase of hepatogenesis. J Hepatol 34:955–961
Gouysse G, Franchon S, Hervieu V et al (2004) Endothelial cell differentiation in hepatocellular adenomas: implications for histopathological diagnosis. J Hepatol 41:259–266
Graveel CR, Jatkoe T, Madore SJ et al (2001) Expression profiling and identification of npvel genes in hepatocellular carcinomas. Oncogene 20:2704–2712
Gray SG, Hartmann W, Eriksson T et al (2000) Expression of genes involved with cell cycle control, cell growth and chromatin modification are altered in hepatoblastomas. Int J Mol Med 6:161–169
Haas JE, Muczynski KA, Krailo M et al (1989) Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 64:1082–1095
Haas JE, Feusner JH, Finegold MJ (2001) Small cell undifferentiated histology in hepatoblastoma may be unfavorable. Cancer 92:3130–3134
Halasz J, Holczbauer A, Paska C et al (2006) Claudin-1 and claudin-2 differentiate fetal from embryonal components in human hepatoblastoma. Hum Pathol 37:555–561
Hansen K, Bagtas J, Mark HF et al (1992) Undifferentiated small cell hepatoblastoma with a unique chromosomal translocation: a case report. Pediatr Pathol 12:457–462
Hartmann W, Waha A, Koch A et al (2000) p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19. Am J Pathol 157:1393–1403
Heerema-McKenney A, Leuschner I, Smith N et al (2005) Nested stromal epithelial tumor of the liver: six cases of a distinctive pediatric neoplasm with frequent calcifications and association with Cushing syndrome. Am J Surg Pathol 29:10–20
Heifetz SA, French M, Correa M et al (1997) Hepatoblastoma: the Indiana experience with preoperative chemotherapy for inoperable tumors; clinicopathological considerations. Pediatr Pathol Lab Med 17:857–874
Hill DA, Swanson PE, Anderson K et al (2005) Desmoplastic nested spindle cell tumor of liver: report of four cases of a proposed new entity. Am J Surg Pathol 29:1–9
Hirohashi S, Ishak KG (2000) Tumours of the liver and intrahepatic bile ducts. In: Hamilton SR, Aaltonen LA (eds) Pathology and genetics of tumours of the digestive system. IARC Press, Lyon
Honda S, Arai Y, Haruta M et al (2008) Loss of imprinting of IGF2 correlates with hypermethylation of teh H19 differentially methylated region in hepatoblastoma. Br J Cancer 99:1891–1899
Http://seer.cancer.gov Surveillance Epidemiology and End Results Web site
Hung W, Blizzard RM, Migeon CJ et al (1963) Precocious puberty in a boy with hepatoma and circulating gonadotropin. J Pediatr 63:895–903
Ingram DJ, Yerushalmi B, Connell J et al (2000) Hepatoblastoma in a neonate: a hypervascular presentation mimicking hemangioendothelioma. Pediatr Radiol 30:794–797
Iolascon A, Giordani L, Moretti A et al (1998) Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma. Hepatology 27:989–995
Ishak KG, Glunz PR (1967) Hepatoblastoma and hepatocarcinoma in infancy and childhood. Cancer 20:396–422
Ishak KG, Goodman ZD (1999) Hepatocellular carcinoma. In: Ishak KG, Goodman ZD, Stocker JT (eds) Tumors of the liver and intrahepatic bile ducts. Armed Forces Institute of Pathology, Washington
Joshi VV, Kaur P, Ryan B et al (1984) Mucoid anaplastic hepatoblastoma. A case report. Cancer 54:2035–2039
Kakar S, Burgart LJ, Batts KP et al (2005) Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod Pathol 18:1417–1423
Kakar S, Chen X, Ho C et al (2009) Chromosomal changes in fibrolamellar hepatocellular carcinoma detected by array comparative genomic hybridization. Mod Pathol 22:134–141
Kannangai R, Vivekanandan P, Martinez-Murillo F et al (2007) Fibrolamellar carcinomas show overexpression of genes in the RAS, MAPK, PIK3, and xenobiotic degradation pathways. Hum Pathol 38:639–644
Kasai M, Watanabe I (1970) Histologic classification of liver-cell carcinoma in infancy and childhood and its clinical evaluation. Cancer 25:552–563
Katzenstein HM, Krailo MD, Malogolowkin MH et al (2002) Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children’s Cancer Group intergroup study. J Clin Oncol 20:2789–2797
Katzenstein HM, Krailo MD, Malogolowkin MH et al (2003) Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 97:2006–2012
Kaufman SS, Wood RP, Shaw BW et al (1987) Hepatocarcinoma in a child with the Alagille syndrome. Am J Dis Child 141:698–700
Kim L, Park YN, Kim SE et al (2001) Teratoid hepatoblastoma: multidirectional differentiation of stem cell of the liver. Yonsei Med J 42:431–435
Kingston JE, Draper GJ, Mann JR et al (1982) Hepatoblastoma and polyposis coli. Lancet 1:457
Kumar EV, Kumar L, Pathak IC et al (1978) Clinical, hormonal and ultrastructure studies of a virilizing hepatoblastoma. Acta Paediatr Scand 67:389–392
LaBrecque D (1996) Neoplasia of the liver. Liver and biliary disease. W Wilkens, Baltimore, pp 391–438
Lack EE, Neave C, Vawter GF (1982) Hepatoblastoma. A clinical and pathologic study of 54 cases. Am J Surg Pathol 6:693–705
Lack EE, Neave C, Vawter GF et al (1983) Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence. Cancer 52:1510–1515
Lai CL, Wu PC, Lam KC et al (1979) Histologic prognostic indicators in hepatocellular carcinoma. Cancer 44:1677–1683
Lau WY, Lai PB, Leung MF et al (2000) Differential gene expression of hepatocellular carcinoma using cDNA microarray analysis. Oncol Res 12:59–69
Lee JS, Thorgeirsson SS (2004) Genome-scale profiling of gene expression in hepatocellular carcinoma: classification, survival prediction, and identification of therapeutic targets. Gastroenterology 127(Suppl 1):S51–S55
Lee JS, Thorgeirsson SS (2005) Genetic profiling of human hepatocellular carcinoma. Semin Liver Dis 25:125–132
Lefkowitch JH, Muschel R, Price JB et al (1983) Copper and copper-binding protein in fibrolamellar liver cell carcinoma. Cancer 51:97–100
Li X, Adam G, Cui H et al (1995) Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting. Oncogene 11:221–229
Li C, Tan YX, Zhou H et al (2005) Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: identification of potential tumors markers. Proteomics 5:1125–1139
Libbrecht L, De Vos R, Cassiman D et al (2001) Hepatic progenitor cells in hepatocellular adenomas. Am J Surg Pathol 25:1388–1396
Libbrecht L, Desmet V, Roskams T (2003) Stages of normal and aberrant intrahepatic bile duct development in a mixed hepatoblastoma. Histopathology 42:618–620
Lopez-Terrada D, Gunaratne PH, Adesina AA et al (2009a) Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors. Hum Pathol 40:783–794
Lopez-Terrada D, Patel K et al (2009b) Characteristic chromosomal copy number changes are associated with subtypes of hepatoblastoma and HCC identified by array-CGH analysis. Society of Pediatric Pathology, Boston
Lowichik A, Zhou H, Pysher TJ et al (2000) Therapy associated changes in childhood tumors. Adv Anat Pathol 7:341–359
Lu M, Greer ML (2007) Hypervascular multifocal hepatoblastoma: dynamic gadolinium-enhanced MRI findings indistinguishable from infantile hemangio-endothelioma. Pediatr Radiol 37:587–591
Luo JH, Ren B, Keryanov S et al (2006) Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 44:1012–1024
Manes JL, Kissane JM, Valdes AJ et al (1977) Congenital hepatic fibrosis, liver cell carcinoma and adult polycystic kidneys. Cancer 39:2619–2623
Manivel C, Wick MR, Abenoza P et al (1986) Teratoid hepatoblastoma. The nosologic dilemma of solid embryonic neoplasms of childhood. Cancer 57:2168–2174
Matsubara K, Tokino T (1990) Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis. Mol Biol Med 7:243–260
Meir K, Maly A, Doviner V et al (2009) Nested (ossifying) stromal epithelial tumor of the liver: case report. Pediatr Dev Pathol 12:233–236
Meyers RL (2007) Tumors of the liver in children. Surg Oncol 16:195–203
Milman DH, Grayzel DM (1951) Mixed tumor of the liver; report of a case with a review of the literature. AMA Am J Dis Child 81:408–420
Misick OS (1898) A case of teratoma hepatis. J Pathol Bact 5:128–137
Misugi K, Okajima H, Misugi N et al (1967) Classification of primary malignant tumors of liver in infancy and childhood. Cancer 20:1760–1771
Montesano R (2002) Hepatitis B immunization and hepatocellular carcinoma: the Gambia Hepatitis Intervention Study. J Med Virol 67:444–446
Moore SW, Hesseling PB (1997) Hepatocellular carcinoma in children. Pediatr Surg Int 12:266–270
Moritake H, Taketomi A, Kamimura S et al (2000) Renin-producing hepatoblastoma. J Pediatr Hematol Oncol 22:78–80
Nakagawara A, Ikeda K, Hayashida Y et al (1982) Immunocytochemical identification of human chorionic gonadotropin- and alpha-fetoprotein-producing cells hepatoblastoma associated with precocious puberty. Virchows Arch A Pathol Anat Histopathol 398:45–51
Nakagawara A, Ikeda K, Tsuneyoshi M et al (1985) Hepatoblastoma producing both alpha-fetoprotein and human chorionic gonadotropin. Clinicopathologic analysis of four cases and a review of the literature. Cancer 56:1636–1642
Neimann N, Rauber G, Manciaux N (1963) Les tumeurs malignes du foie chez l’enfant. Rev Int Hepat 13:81–129
Nzeako UC, Goodman ZD, Ishak KG (1995) Comparison of tumor pathology with duration of survival of North American patients with hepatocellular carcinoma. Cancer 76:579–588
Okabe H, Satoh S, Kato T et al (2001) Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 61:2129–2137
Ortega JA, Douglass EC, Feusner JH et al (2000) Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of paediatric hepatoblastoma: a report from the Children’s Cancer Group and the Paediatric Oncology Group. J Clin Oncol 18:2665–2675
Pakakasama S, Chen TT, Frawley W et al (2004) CCND1 polymorphism and age on onset of hepatoblastoma. Oncogene 23:4789–4792
Pang SC (1961) Bony and cartilaginous hepatoblastoma. J Pathol Bacteriol 82:273–280
Parham DM, Weeks DA, Beckwith JB (1994) The clinicopathologic spectrum of putative extrarenal rhabdoid tumors. An analysis of 42 cases studied with immunohistochemistry or electron microscopy. Am J Surg Pathol 18:1010–1029
Park WS, Oh RR, Park JY et al (2001) Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma. J Pathol 193:483–490
Parker P, Burr I, Slonim A et al (1981) Regression of hepatic adenomas in type Ia glycogen storage disease with dietary therapy. Gastroenterology 81:2129–2137
Pinna AD, Iwatsuki S, Lee RG et al (1997) Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 26:877–883
Prokurat A, Kluge P, Kosciesza A et al (2002) Transitional liver cell tumors (TLCT) in older children and adolescents: a novel group of aggressive hepatic tumors expressing beta-catenin. Med Pediatr Oncol 39:510–518
Rabinovitz M, Imperial JC, Schade RR et al (1989) Hepatocellular carcinoma in Alagille’s syndrome: a family study. J Pediatr Gastroenterol Nutr 8:26–30
Rainier S, Dobry CJ, Feinberg AP (1995) Loss of imprinting in hepatoblastoma. Cancer Res 55:1836–1838
Ramsay AD, Bates AW, Williams S et al (2008) Variable antigen expression in hepatoblastomas. Appl Immunohistochem Mol Morphol 16:140–147
Robinson HB, Bolande RP (1985) Case 3. Fetal hepatoblastoma with placental metastases. Pediatr Pathol 4:163–167
Rod A, Voicu M, Chiche L et al (2009) Cushing’s syndrome associated with a nested stromal epithelial tumor of the liver: hormonal, immunohistochemical, and molecular studies. Eur J Endocrinol 161:805–810
Ross JA, Radloff GA, Davies SM (2000) H19 and IGF-2 allele-specific expression in hepatoblastoma. Br J Cancer 82:753–756
Rowland JM (2002) Hepatoblastoma: assessment of criteria for histologic classification. Med Pediatr Oncol 39:478–483
Ruck P, Kaiserling E (1993) Melanin-containing hepatoblastoma with endocrine differentiation. An immunohistochemical and ultrastructural study. Cancer 72:361–368
Rugge M, Sonego F, Pollice L et al (1998) Hepatoblastoma: DNA nuclear content, proliferation indices, and pathology. Liver 18:128–133
Russo P, Biegel JA (2009) SMARCB1/INI1 alterations and hepatoblastoma: another extrarenal rhabdoid tumor revealed? Pediatr Blood Cancer 52:312–313
Saul SH, Titelbaum DS, Gansler TS et al (1987) The fibrolamellar variant of hepatocellular carcinoma. Its association with focal nodular hyperplasia. Cancer 60:3049–3055
Saxena R, Leake JL, Shafford EA et al (1993) Chemotherapy effects on hepatoblastoma. A histological study. Am J Surg Pathol 17:1266–1271
Scheimberg I, Cullinane C, Kelsey A et al (1996) Primary hepatic malignant tumor with rhabdoid features. A histological, immunocytochemical, and electron microscopic study of four cases and a review of the literature. Am J Surg Pathol 20:1394–1400
Schlecht I, Riebel T, Henze G (1996) Unusually intensively ossified hepatoblastoma (teratoid type) in a 1-year-old girl (in German). Rofo 165:201–203
Shang XZ, Zhu H, Lin K et al (2004) Stabilized beta-catenin promotes hepatocyte proliferation and inhibits TNFalpha-induced apoptosis. Lab Invest 84:332–341
Shirota Y, Kaneko S, Honda M et al (2001) Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays. Hepatology 33:832–840
Siciliano M, De Candia E, Ballarin S et al (2000) Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease. J Clin Gastroenterol 31:80–82
Simson IW (1982) Membranous obstruction of the inferior vena cava and hepatocellular carcinoma in South Africa. Gastroenterology 82:171–178
Sinniah D, Campbell PE, Colebatch JH (1974) Primary hepatic cancer in childhood. Arch Dis Child 49:496
Soreide O, Czerniak A, Bradpiece H et al (1986) Characterstics of fibrolamellar hepatocellular carcinoma. A study of nine cases and a review of the literature. Am J Surg 151:518–523
Stocker JT (1994) Hepatoblastoma. Semin Diagn Pathol 11:136–143
Stocker JT (2001) Hepatic tumors in children. Clin Liver Dis 5:259–281
Taat F, Bosman DK, Aaronson DC (2004) Hepatoblastoma in a girl with biliary atrasia: coincidence or co-incidence. Pediatr Blood Cancer 43:603–605
Takayasu H, Horie H, Hiyama E et al (2001) Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma. Clin Cancer Res 7:901–908
Thomas D, Pritchard J, Davidson R et al (2003) Familia hepatoblastoma and APC gene mutations: renewed call for molecular research. Eur J Cancer 39:2200–2204
Thorgeirsson SS, Grisham JW (2002) Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31:339–346
Tomizawa M, Saisho H (2006) Signaling pathway of insulin-like growth factor-II as a target of molecular therapy for hepatoblastoma. Wordl J Gastroenterol 12:6531–6535
Tornillo L, Carafa V, Sauter G et al (2002) Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplasic nodules represent early stages of hepatocellular carcinoma. Lab Invest 82:547–553
Touraine RL, Bertrand Y, Foray P et al (1993) Hepatic tumours during androgen therapy in Fanconi anemia. Eur J Pediatr 152:691–693
Trobaugh-Lotrario AD, Tomlinson GE, Finegold MJ et al (2009) Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors. Pediatr Blood Cancer 52:328–334
Tsai HW, Tsai HH, Kuo FY et al (2009) Computerized analyses of morphology and proliferative activity differentiate hepatoblastoma from paediatric hepatocellular carcinoma. Histopathology 54:328–336
Ucar C, Caliskan U, Troy H et al (2005) Hepatoblastoma in a child with neurofibromatosis type 1. Pediatr Blood Cancer 49:357–359
Van Dyck F, Declercq J, Braem CV et al (2007) PLAG1, the prototype of the PLAG gene family: versatility in tumour development. Int J Oncol 30:765–774
Van Eyken P, Sciot R, Callea F et al (1990) A cytokeratin-immunohistochemical study of hepatoblastoma. Hum Pathol 21:302–308
Varma V, Cohen C (2004) Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma. Adv Anat Pathol 11:239–249
Vileisis RA, Sorensen K, Gonzalez-Crussi F et al (1982) Liver malignancy after parenteral nutrition. J Pediatr 100:88–90
Vivekanandan P, Thomas D, Torbenson M et al (2009) Methylation regulates hepatitis B viral protein expression. J Infect Dis 199:1286–1291
Von Schweinitz D, Wischmeyer P, Leuschner I et al (1994) Clinico-pathological criteria with prognostic relevance in hepatoblastoma. Eur J Cancer 30A:1052–1058
Wagner LM, Garrett JK, Ballard ET et al (2007) Malignant rhabdoid tumor mimicking hepatoblastoma: a case report and literature review. Pediatr Dev Pathol 10:409–415
Wang J, Chenivesse X, Henglein B et al (1990) Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 343:555–557
Watanabe I, Kasai M, Watanuki T et al (1975) Malignant mixed tumor of the liver: report of a case and a review of the literature. Acta Hepatogastroenterol (Stuttg) 22:158–164
Watanabe I, Yamaguchi M, Kasai M (1987) Histologic characteristics of gonadotropin-producing hepatoblastoma: a survey of seven cases from Japan. J Pediatr Surg 22:406–411
Wei Y, Fabre M, Branchereau S et al (2000) Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. Oncogene 19:498–504
Weinberg AG, Mize CE, Worthen HG et al (1976) The occurrence of hepatoma in the chronic form of hereditary tyrosinemia. J Pediatr 88:434–438
Weinberg AG, Finegold MJ (1983) Primary hepatic tumors of childhood. Hum Pathol 14:512–537
Weinstein S, Scottolini AG, Loo SY et al (1985) Ataxia telangiectasia with hepatocellular carcinoma in a 15-year-old girl and studies of her kindred. Arch Pathol Lab Med 109:1000–1004
Wilkens L, Bredt M, Flemming P et al (2000) Cytogenetic aberrations in primary and recurrent fibrolamellar hepatocellular carcinoma detected by comparative genomic hybridization. Am J Clin Pathol 114:867–874
Willis RA (1962) The Pathology of tumours of children. Charles C. Thomas, Springfield
Wong N, Lai P, Pang E et al (2000) A comprehensive karyotypic study on human hepatocellular carcinoma by spectral karyotyping. Hepatology 32:1060–1068
Wu PC, Fang JW, Lau VK et al (1996) Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am J Pathol 149:1167–1175
Yamada S, Ohira M, Horie H et al (2004) Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as poor-prognosis indicator of hepatoblastomas. Oncogene 23:5901–5911
Yamaoka H, Ohtsu K, Sueda T et al (2006) Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors. Oncol Rep 15:551–556
Yamauchi N, Watanabe A, Hishinuma M et al (2005) The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. Mod Pathol 18:1591–1598
Yang J, Zhou F, Xu T et al (2008) Analysis of sequence variations in 59 microRNAs in hepatocellular carcinoma. Mutat Res 638:205–209
Yun K, Jinno Y, Sohda T et al (1998) Promoter-specific insulin-like growth factor 2 gene imprinting in human fetal liver and hepatoblastoma. J Pathol 185:91–98
Zatkova A, Rouillard JM, Hartmann W et al (2004) Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma. Genes Chromosomes Cancer 39:126–137
Zerbini MC, Sredni ST, Grier H et al (1998) Primary malignant epithelial tumors of the liver in children: a study of DNA content and oncogene expression. Pediatr Dev Pathol 1:270–280
Zimmermann A (2000) Tumors of the liver – pathologic aspects. In: Blumgart LH (ed) Surgery of the liver, biliary tract and pancreas, vol II, 4th edn. Saunders Elsevier, Philadelphia, pp 1085–1130, Section 13, Chapter 69
Zimmermann A (2002) Hepatoblastoma with cholangioblastic features (‘cholangioblastic hepatoblastoma’) and other liver tumors with bimodal differentiation in young patients. Med Pediatr Oncol 39:487–491
Zimmermann A (2005) The emerging family of hepatoblastoma tumours: from ontogenesis to oncogenesis. Eur J Cancer 41:1503–1514
Zimmermann A (2006) Malignant epithelial liver tumors in children, adolescents and adults: molecular pathways of cancerogenesis, growth, and spread. In: Lee F (ed) Liver cancer: new research. Nova Biomedical Books, New York, pp 1–41, Chapter 1
Zucman-Rossi J, Jeannot E, Nhieu JT et al (2006) Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43:515–524
Zynger DL, Gupta A, Luan C et al (2008) Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases. Hum Pathol 39:224–230
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Berlin Heidelberg
About this chapter
Cite this chapter
Zimmermann, A., Lopez-Terrada, D. (2011). Pathology of Pediatric Liver Tumors. In: Zimmermann, A., Perilongo, G. (eds) Pediatric Liver Tumors. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-14504-9_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-14504-9_9
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-14503-2
Online ISBN: 978-3-642-14504-9
eBook Packages: MedicineMedicine (R0)